Publication:
Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?

dc.contributor.authorMutlu, Deniz
dc.contributor.authorIliescu, Cezar A.
dc.contributor.authorAteş, İsmail
dc.contributor.authorÇilingiroğlu, Mehmet
dc.contributor.authorMarmagkiolis, Konstantinos
dc.contributor.institutionİSTANBUL ÜNİVERSİTESİ - CERRAHPAŞA
dc.contributor.institutionYabancı Kurumlar
dc.contributor.institutionBAHÇEŞEHİR ÜNİVERSİTESİ
dc.contributor.institutionTanımlanmamış Kurum
dc.contributor.institutionYabancı Kurumlar
dc.date.accessioned2025-09-20T19:58:06Z
dc.date.issued2021
dc.date.submitted09.10.2021
dc.description.abstractVentricular septal defect (VSD) is one of the most common congenital heart diseases worldwide today.Although the majority close spontaneously, transcatheter VSD closure is a common option for symptomaticpatients with suitable anatomy in adult age. Although transesophageal echocardiography (TEE) and intracardiac echocardiography are the most common imaging modalities for the procedure, in patients with poorTEE images, Transthoracic echocardiography (TTE) can be used as a reliable alternative. Here we present anadult patient with pulmonary hypertension associated with a muscular VSD which was closed percutaneouslyusing 2-dimensional TTE because of poor TEE images
dc.identifier.endpage147
dc.identifier.issn1308-8734
dc.identifier.issn1308-8742
dc.identifier.issue2
dc.identifier.startpage144
dc.identifier.urihttps://hdl.handle.net/20.500.14719/4950
dc.identifier.volume53
dc.language.isoen
dc.relation.journalEurasian Journal of Medicine
dc.subjectKalp ve Kalp Damar Sistemi
dc.titlePercutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography: Can We Sufficiently Visualize It?
dc.typeLetter To Editor
dcterms.references1. Bernier PL, Stefanescu A, Samoukovic G, Tchervenkov CI. The challenge of congenital heart disease worldwide: epidemiologic and demographic facts. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2010,13(1):26-34. [Crossref],2. Penny DJ, Vick GW 3rd. Ventricular septal defect. Lancet. 2011,377(9771):1103-1112. [Crossref],3. Stout KK, Daniels CJ, Aboulhosn JA, et al. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2019,73(12):1494-1563. [Crossref],4. Spicer DE, Hsu HH, Co-Vu J, Anderson RH, Fricker FJ. Ventricular septal defect. Orphanet J Rare Dis. 2014,9:144. [Crossref],5. Lasala, JM. Catheter-Based Treatment of Congenital Heart Disease in Adults. In: Zipes D, Libby P, eds. Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine. Elsevier, 2019:1574–1579.,6. Tanidir IC, Baspinar O, Saygi M, Kervancioglu M, Guzeltas A, Odemis E. Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: a multicentre study. Int J Cardiol. 2020,310:43-50. [Crossref],7. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation. 1988,78(2):361-368. [Crossref],8. Butera G, Carminati M, Chessa M, et.al. Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. J Am Coll Cardiol. 2007,50(12):1189-1195. [Crossref],9. Zhang GC, Chen Q, Cao H, Chen LW, Yang LP, Chen DZ. Minimally invasive perventricular device closure of ventricular septal defect in infants under transthoracic echocardiograhic guidance: feasibility and comparison with transesophageal echocardiography. Cardiovasc Ultrasound. 2013,11:8. [Crossref]
dspace.entity.typePublication
local.indexed.atTRDizin

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Percutaneous Muscular Ventricular Septal Defect Closure with 2D Transthoracic Echocardiography Can We Sufficiently Visualize It.pdf
Size:
875.31 KB
Format:
Adobe Portable Document Format